← Evidence map

ArticleBritish journal of cancer2026

Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition, regardless of HRR status.

Mohamed E Elsesy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition, regardless of HRR status. | OpenQuestion